A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,

Slides:

Advertisements

Similar presentations

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD

Advertisements

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer Pierre-Benoit Pagès, MD, Pierre Mordant,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Andranik Petrosyan, MD, Patrice Bergeron, MD

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum Kenneth A. Kesler, MD, Laura E. Kruter,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgical Treatment of Metachronous Second Primary Lung Cancer

Quality Indicators for Non-Small Cell Lung Cancer Operations With Use of a Modified Delphi Consensus Process Gail Darling, MD, Richard Malthaner, MD,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Pleural Metastasis of Osteosarcoma

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection Shiro Nagatani, MD, Yutaka Shimada,

Lymph Node Staging by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients With Small Cell Lung Cancer Hironobu Wada, MD, Takahiro.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mark W. Hennon, MD, Elisabeth U

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Marc Riquet, MD, PhD, Patrick Bagan,

The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Surgical Resection of Pulmonary Malignant Tumors After Living Donor Liver Transplantation Fumihiro Shoji, MD, Daigo Kawano, MD, Toru Ikegami, MD, Yuji.

Presentation transcript:

A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD, Yuji Matsumura, MD, PhD, Nobuyuki Sato, MD, PhD, Hiroyuki Deguchi, MD, PhD, Hiroyuki Oizumi, MD, PhD, Motoyasu Sagawa, MD, PhD, Takao Tsushima, MD, PhD, Satomi Takahashi, MD, PhD, Jotaro Shibuya, MD, PhD, Masahide Hirose, MD, PhD, Takashi Kondo, MD, PhD The Annals of Thoracic Surgery Volume 98, Issue 1, Pages 258-264 (July 2014) DOI: 10.1016/j.athoracsur.2014.01.052 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 CONSORT (consolidated standards of reporting trials) diagram. CWI = chest wall invasion; N2 = multiple mediastinal lymph node metastasis; PD = pleural dissemination; SCLC = small cell lung cancer; SRS = stereotactic radiosurgical treatment. Shaded boxes indicate patients undergoing complete resection of both primary and metastatic sites. The Annals of Thoracic Surgery 2014 98, 258-264DOI: (10.1016/j.athoracsur.2014.01.052) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival of patients undergoing complete resection of both primary and metastatic sites. Patients undergoing complete resection of both primary tumor and metastasis had a 5-year survival of 44.7%. The Annals of Thoracic Surgery 2014 98, 258-264DOI: (10.1016/j.athoracsur.2014.01.052) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions